Skip to content

Clinical trials

Terminated Alzheimer Disease trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Alzheimer Disease Status: Terminated Country / region: Taiwan Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20141
20151
20163
20172
20182
20201
20211
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated13

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche3
Biogen2
Eli Lilly and Company2
AstraZeneca1
Axovant Sciences Ltd.1
GlaxoSmithKline1
Novartis Pharmaceuticals1
TauRx Therapeutics Ltd1
United Neuroscience Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Alzheimer Disease13
Brain Diseases3
Dementia3
Central Nervous System Diseases2
Mental Disorders2
Nervous System Diseases2
Neurodegenerative Diseases2
Cognitive Dysfunction1
Delirium1
Frontotemporal Dementia1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.